SG
WST icon

Sienna Gestion’s West Pharmaceutical WST Stock Holding History

Sienna Gestion’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,798
Closed -$4.27M – 192
2024
Q1 		$4.27M Buy
+10,798
New +$3.99M 0.37% 104

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sienna Gestion's WST Position: Q2 2024 in Review

Sienna Gestion sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 10,798 shares — an estimated $4.27M sold.

Sienna Gestion first reported a position in WST in Q1 2024 and held it in 1 quarter. The position peaked at $4.27M in Q1 2024. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Sienna Gestion reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Sienna Gestion sold 10,798 West Pharmaceutical shares in Q2 2024, an estimated $4.27M.
  • Sienna Gestion first reported a position in West Pharmaceutical in Q1 2024 and held it in 1 quarter.
  • Sienna Gestion's West Pharmaceutical position peaked at $4.27M in Q1 2024.
  • 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Sienna Gestion's 13F filing for Q2 2024, filed 12 Aug 2024.